These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 21211590

  • 1. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 2. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan 11; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 3. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 11; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 4. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Bashkin A, Mandelboim M, Litinsky I, Comaheshter D, Levartovsky D, Mendelson E, Wigler I, Caspi D, Paran D.
    Semin Arthritis Rheum; 2010 Jun 11; 39(6):442-7. PubMed ID: 19246078
    [Abstract] [Full Text] [Related]

  • 5. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.
    Arthritis Rheum; 2010 Jan 11; 62(1):64-74. PubMed ID: 20039397
    [Abstract] [Full Text] [Related]

  • 6. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
    Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.
    Clin Exp Immunol; 2014 Oct 11; 178(1):40-7. PubMed ID: 24889761
    [Abstract] [Full Text] [Related]

  • 7. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.
    Rehnberg M, Brisslert M, Amu S, Zendjanchi K, Håwi G, Bokarewa MI.
    Arthritis Res Ther; 2010 Oct 11; 12(3):R111. PubMed ID: 20529331
    [Abstract] [Full Text] [Related]

  • 8. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL, Kivitz AJ, Birbara C, Luo AY.
    J Rheumatol; 2007 Feb 11; 34(2):272-9. PubMed ID: 17304653
    [Abstract] [Full Text] [Related]

  • 9. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
    Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.
    Rheumatology (Oxford); 2007 Apr 11; 46(4):608-11. PubMed ID: 17114801
    [Abstract] [Full Text] [Related]

  • 10. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.
    Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.
    Ann Rheum Dis; 2011 Dec 11; 70(12):2144-7. PubMed ID: 21859696
    [Abstract] [Full Text] [Related]

  • 11. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug 11; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

  • 12. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y.
    Arthritis Rheum; 2011 Dec 11; 63(12):3692-701. PubMed ID: 22127692
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O.
    Clin Dev Immunol; 2006 Dec 11; 13(2-4):349-51. PubMed ID: 17162376
    [Abstract] [Full Text] [Related]

  • 14. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.
    Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, Anandarajah AP, Looney RJ, Thiele RG, Anolik JH, Coca A, Wei C, Rosenberg AF, Feng C, Treanor JJ, Lee FE, Sanz I.
    Arthritis Res Ther; 2011 Dec 11; 13(6):R209. PubMed ID: 22177419
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr 11; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 16. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study.
    Gabay C, Bel M, Combescure C, Ribi C, Meier S, Posfay-Barbe K, Grillet S, Seebach JD, Kaiser L, Wunderli W, Guerne PA, Siegrist CA, H1N1 Study Group.
    Arthritis Rheum; 2011 Jun 11; 63(6):1486-96. PubMed ID: 21384334
    [Abstract] [Full Text] [Related]

  • 17. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
    Muller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J.
    Clin Exp Rheumatol; 2013 Jun 11; 31(5):723-30. PubMed ID: 23806224
    [Abstract] [Full Text] [Related]

  • 18. [Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response].
    Francioni C, Rosi P, Fioravanti A, Megale F, Pipitone N, Marcolongo R.
    Recenti Prog Med; 1996 Apr 11; 87(4):145-9. PubMed ID: 8643873
    [Abstract] [Full Text] [Related]

  • 19. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.
    J Rheumatol; 2014 Apr 11; 41(4):648-57. PubMed ID: 24584918
    [Abstract] [Full Text] [Related]

  • 20. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N, Mimori T.
    Clin Calcium; 2007 Apr 11; 17(4):569-76. PubMed ID: 17404487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.